Titan Pharmaceuticals

View the org chart displaying its 8 main executives

Most searched biographies at Titan Pharmaceuticals

• David Lazar, Interim Chairman of the Board
• Seow Gim Shen, Director
• Avraham Ben-Tzvi, Director

Popular executive movements at Titan Pharmaceuticals

• Seow Gim Shen has joined the company as Director  (posted on October 17 2023).
• Brynner Chaim has joined the company as Director  (posted on October 17 2023).

Create your alert
to follow the executive moves at Titan Pharmaceuticals.

Titan Pharmaceuticals has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Titan Pharmaceuticals

• Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
• Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
• Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors
• Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock
• Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets
• Titan Pharmaceuticals Provides Shareholder Update
• UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.
• Titan Pharmaceuticals Announces Board Expansion and Management Changes
• Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant
• Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus :: Titan Pharmaceuticals, Inc. (TTNP)
• View more press releases Close

Social media about Titan Pharmaceuticals

• Titan Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Titan Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including David Lazar

Call Titan Pharmaceuticals at +1 650...

View the org chart

Register to receive your alert

Report an error